-
481por Wang, Bei, Li, Hai-jun, Cai, Mi-mi, Lin, Zhao-xin, Ou, Xia-fei, Wu, Shu-hua, Cai, Rui-huan, Wei, Ying-na, Yang, Fei, Zhu, Ya-min, Yang, Zi-feng, Zhong, Nan-shan, Lin, Ling“…A safety evaluation was performed to record and analyse all adverse events that occurred during and after drug administration as well as any cases in which dosing was halted because of these events. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
482por Hussain, Mariam, Reddy, Tina K, Mohiuddin, Arianna, Lovre, Dragana, Galagan, Robert“…He was transitioned to a medical ward when his severe hypocalcemia was corrected and he was ultimately discharged on oral calcitriol 1 mcg BID and calcium carbonate 1000 mg po TID. A thorough workup for a cause of the hypoparathyroidism was performed, including anti-PTH antibody, 21-hydroxylase antibody, TSI, and TPO antibody, all of which were negative. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483por Romo, Karina G, Shu, Sharon, Gabriel, Mary, Bhamre, Sneha, Iqbal, Qasim Z, Noor, Abdulla A, Uwaifo, Gabriel I“…She was additionally prescribed GC therapy of hydrocortisone 10mg TID following her diagnosis of NCCAH. She subsequently became pregnant unexpectedly. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
484“…Two weeks later she was seen in primary care clinic with BG of 36 mg/dl when all insulin was stopped. One week later she was seen in the emergency room with BG of 37mg/dl. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485por Zargari, Iren, Adar, Adi, Keidar, Rimona, Eyal, Ori, Loewenthal, Neta, Pinhas-Hamiel, Orit, Morag, Iris, Levy, Milana, Dally-Gottfried, Orna, Landau, Zohar, Levy-Khademi, Floris, Zangen, David, Eventov-Friedman Smadar, Smadar, Youngster, Ilan, Rachmiel, Marianna“…Preterm subjects who were born between 1990-2013, and developed T1D before the age of 18 years (T1D group), were paired with subjects who didn't develop TID (Control group) at a ratio of 1:3 by: gender, gestational age (GA), month of birth and birth medical center . …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486por Kasthuri, Selvam, Poongothai, Subramani, Anjana, Ranjit Mohan, Selvakumar, Jayvel, Muthukumar, Subramaniam, Kayalvizhi, Sengottuevel, Tariq, Syed, Honey, Evangelin, Gupta, Prasanna Kumar, Venkatesan, Ulagamathesan, Mohan, Viswanathan“…The patients were randomized at visit 2 (day 0 ± 2) to receive Voglibose 0.2 or 0.3 mg tablets (BID/TID) as add-on therapy to Met and Met+SU. All the patients were followed at day 14 ± 2 (visit 3), month 3 ± 14 days (visit 4), 14 weeks (i.e., visit 4 + 14 days) ±2 days (visit 5), and month 6 ± 14 days (visit 6). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
487“…Patient was discharged on glargine 40 units SC BID and aspart 10 units SC TID AC. Seventeen days after discharge, patient was admitted with hyperglycemia (233 mg/dL), hypokalemia (2.5 mg/dL), abdominal pain, nausea, and vomiting. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
488por Foussias, George, Rao, Naren, Fervaha, Gagan, Borlido, Carol, Haber, Lillian, Takeuchi, Hiroyoshi, Mizrahi, Romina, Remington, Gary“…Participants were treated with adjunctive open-label levodopa/carbidopa, with dose titration to levodopa 300mg TID over 38 days as tolerated, and dose maintenance for the remainder of the eight-week trial. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
489por Soares, Maria Marta Sarquis, Schutze, Luísa Lima Castro, Garcia, Luciana Cristian Coelho, Leão felipealeao@hotmail.com, Felipe Augusto Azevedo, Maia, Lilian Mara Nunes, Alkmim, Nina Ramalho, Saraiva, Maria Fernanda Marinho, Soares, Beatriz Santana“…She used paracetamol 750mg t.i.d for seven days. After that, she noticed jaundice and sought medical care. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
490por Pernegger, H., Allport, P., Berlea, D.V., Birman, A., Bortoletto, D., Buttar, C., Charbon, E., Dachs, F., Dao, V., Denizli, H., Dobrijevic, D., Dyndal, M., Fenigstein, A., de Acedo, L. Flores Sanz, Freeman, P., Gabrielli, A., Gazi, M., Gonella, L., Gonzalez, V., Gustavino, G., Haim, A., Kugathasan, T., LeBlanc, M., Munker, M., Oyulmaz, K.Y., Piro, F., Riedler, P., Sandaker, H., Schioppa, E.J., Sharma, A., Snoeys, W., Solans Sanchez, C., Suligoj, T., Toledano, E., van Rijnbach, M., Nunez, M. Vazquez, Weick, J., Worm, S., Zoubir, A.M.“…The design targets radiation hardness of > 10$^{15}$ (1 MeV) n$_{eq}$/cm$^{2}$ and 100 Mrad TID. The sensor shall operate as tracking sensor with a spatial resolution of ≈ 10 μm and be able to cope with hit rates in excess of 100 MHz/cm$^{2}$ at the LHC bunch crossing frequency of 40 MHz. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
-
491por Mi Kang, Yu, Rubinson, Douglas A, Odintsov, Igor, Vaidya, Anand, Williams, Jonathan S, Kurr Adler, Gail, Elizabeth McDonnell, Marie, Patti, Mary-Elizabeth, Palermo, Nadine E“…Within 20 days, the patient was able to discontinue all diuretics, dexamethasone, and cornstarch. Patient had no side effects related to alpelisib and performance status returned to baseline. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
492por Hakimian, Stephanie, Niznik, Charlotte, El Muayed, Malek, Yee, Lynn, Premkumar, Ashish, Metzger, Boyd, Wallia, Amisha“…Unless otherwise noted, all abstracts presented at ENDO are embargoed until the date and time of presentation. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
493por Welch, Lurah, Welch, Lurah, Maldonado, Leopoldo, Banadera, Felix, Trapane, Pamela, Hasan, Reham, Benson, Matthew, Levine, Michael, Mauras, Nelly“…She has now been followed for 6 months, all fractures are healing with persistently normal PTH and calcium levels. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
494
-
495por Ducher, Annie, Vehreschild, Maria J G T, Vehreschild, Maria J G T, Louie, Thomas J, Cornely, Oliver A, Féger, Céline, Dane, Aaron, Dane, Aaron, Varastet, Marina, de Gunzburg, Jean, Andremont, Antoine, Mentré, France“…METHODS: Hospitalized patients receiving oral/iv fluoroquinolones (FQ) for the treatment of or prophylaxis of febrile neutropenia were randomized to receive DAV132 (7.5g tid orally), or not, during FQ receipt and followed up 51d. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto